Merck Sharp & Dohme Corp.;The Government of the United States of America as represented by the Secretary of the Department of Health and Human Services
发明人:
Kastelein, Robert A.,Cua, Daniel J.,Caspi, Rachel,Tsai, Van T.,Silver, Phyllis,Luger, Dror
申请号：
AU2006284841
公开号：
AU2006284841B2
申请日:
2006.08.30
申请国别(地区):
AU
年份:
2012
代理人:
摘要：
Novel methods and drug products for treating autoimmune ocular inflammatory disease are disclosed, which involve administration of agents that antagonize one or both of IL-17 and IL-23 activity.
